Torcetrapib and Atorvastatin
Atorvastatin
Clinical Pharmacokinetics of Atorvastatin
Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase Inhibitor
Binding interaction of atorvastatin with bovine serum albumin: Spectroscopic methods and molecular docking
Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN)